Literature DB >> 3258758

Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases.

P Matsiota1, A Blancher, B Doyon, B Guilbert, M Clanet, E D Kouvelas, S Avrameas.   

Abstract

Using a panel of antigens (actin, myosin, tubulin, albumin, transferrin, peroxidase, thyroglobulin, DNA, prolactin, TNP and myelin basic protein (MBP], we have tested the antibody activity of serum and cerebrospinal fluid (CSF) from healthy individuals, patients with multiple sclerosis (MS) and individuals with other neurological diseases. No differences in the concentrations and specificities of the serum antibodies were observed among the 3 groups. In contrast, we found that MS patients often had elevated CSF antibody levels against many antigens of the panel. The MS patients with local immunoglobulin production in the central nervous system (CNS) had the highest antibody levels. Restricted antibody activity against a given antigen of the panel was not observed. Compared to the two other groups, the MS group had equivalent titres of anti-MBP antibodies in the CSF. These results suggest that, in MS, a general immune dysregulation exists which leads to a local expansion of B lymphocytes producing autoantibodies with reactivities similar to those of serum natural autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258758     DOI: 10.1016/0769-2625(88)90134-1

Source DB:  PubMed          Journal:  Ann Inst Pasteur Immunol        ISSN: 0769-2625


  12 in total

1.  Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Takahisa Masaki; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-01-02       Impact factor: 3.478

Review 2.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.

Authors:  Lisa K Peterson; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2006-12-28       Impact factor: 3.478

Review 3.  Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Authors:  S F Hunter; M Rodriguez
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Cord blood contains cells secreting antibodies to nervous system components.

Authors:  S Fredrikson; J Sun; B G Xiao; H Link
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 5.  Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Authors:  B G van Engelen; D J Miller; K D Pavelko; O R Hommes; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

6.  Role of CD5+ B-1 cells in EAE pathogenesis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Robert S Fujinami
Journal:  Autoimmunity       Date:  2008-08       Impact factor: 2.815

7.  Cross-reactive myelin antibody induces renal pathology.

Authors:  Lisa K Peterson; Takahisa Masaki; Steven R Wheelwright; Ikuo Tsunoda; Robert S Fujinami
Journal:  Autoimmunity       Date:  2008-11       Impact factor: 2.815

8.  Tryptic peptides of human thyroglobulin: II. Immunoreactivity with sera from patients with thyroid diseases.

Authors:  A M Saboori; P Caturegli; N R Rose; S Mariotti; A Pinchera; C L Burek
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

Review 9.  Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms.

Authors:  H A El-Fawal; S J Waterman; A De Feo; M Y Shamy
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

Review 10.  Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.

Authors:  Michal Schwartz; Oleg Butovsky; Jonathan Kipnis
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.